Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer
Authors:
- Nadia HarbeckNHNadia Harbeck
- Ronald E. KatesRKRonald E. Kates
- Manfred SchmittMSManfred Schmitt
- Katja GaugerKGKatja Gauger
- Marion KiechleMKMarion Kiechle
- Fritz JänickeFJFritz Jänicke
- Christoph ThomssenCTChristoph Thomssen
- Maxime P. LookMLMaxime P. Look
- John A. FoekensJFJohn A. Foekens
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 5 (5) , 348-352
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast CancerJournal of Clinical Oncology, 2003
- Clinical Utility of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor—1 Determination in Primary Breast Cancer Tissue for Individualized Therapy ConceptsClinical Breast Cancer, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2002
- Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1JNCI: Journal of the National Cancer Institute, 2001
- External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsBritish Journal of Cancer, 1998
- Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancerBritish Journal of Cancer, 1997
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for TherapyThrombosis and Haemostasis, 1997
- Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor MarkersJNCI: Journal of the National Cancer Institute, 1996